Renaissance Technologies - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 152 filers reported holding ASSERTIO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$4,066,000
-50.2%
6,255,532
-4.2%
0.00%
-33.3%
Q4 2019$8,162,000
+11.4%
6,529,527
+14.0%
0.01%0.0%
Q3 2019$7,330,000
-58.2%
5,726,289
+12.5%
0.01%
-60.0%
Q2 2019$17,556,000
-33.2%
5,088,689
-1.8%
0.02%
-37.5%
Q1 2019$26,270,000
+55.9%
5,181,427
+11.0%
0.02%
+33.3%
Q4 2018$16,854,000
-34.2%
4,668,591
+7.2%
0.02%
-30.8%
Q3 2018$25,612,0004,355,7380.03%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 3,278,000$11,834,0000.90%
Senvest Management, LLC 2,124,393$7,669,0000.66%
DELTEC ASSET MANAGEMENT LLC 351,176$1,268,0000.35%
PERKINS CAPITAL MANAGEMENT INC 99,600$360,0000.28%
Matarin Capital Management, LLC 838,619$3,027,415,0000.24%
GLOBEFLEX CAPITAL L P 196,357$709,0000.17%
Opaleye Management Inc. 120,000$433,0000.16%
TSP Capital Management Group, LLC 49,175$178,0000.10%
Spark Investment Management LLC 373,609$1,348,0000.09%
Connor, Clark & Lunn Investment Management Ltd. 3,191,964$11,523,0000.08%
View complete list of ASSERTIO THERAPEUTICS INC shareholders